Inflammatory bowel disease (IBD): American College of Gastroenterology’s Annual Scientific Meeting (ACG 2019) presentation points to vedolizumab as an effective pediatric IBD treatment

https://www.mdmag.com/conference-coverage/acg-2019/acg-vedolizumab-pediatric-ibd